Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population

OBJECTIVES: The cost of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) infection may contribute to treatment disparities. However, few data exist on factors associated with DAA initiation. METHODS: We conducted a retrospective cohort study of HCV-infected Kaiser Permanente Norther...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Public Health Rep
Autors principals: Marcus, Julia L., Hurley, Leo B., Chamberland, Scott, Champsi, Jamila H., Gittleman, Laura C., Korn, Daniel G., Lai, Jennifer B., Lam, Jennifer O., Pauly, Mary Pat, Quesenberry, Charles P., Ready, Joanna, Saxena, Varun, Seo, Suk I., Witt, David J., Silverberg, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6055302/
https://ncbi.nlm.nih.gov/pubmed/29750893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0033354918772059
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars